Literature DB >> 31143658

Renal cell carcinoma: preoperative evaluate the grade of histological malignancy using volumetric histogram analysis derived from magnetic resonance diffusion kurtosis imaging.

Ke Wang1, Jingyun Cheng1, Yan Wang1, Guangyao Wu1,2.   

Abstract

BACKGROUND: To investigate the value of histogram analysis of magnetic resonance (MR) diffusion kurtosis imaging (DKI) in the assessment of renal cell carcinoma (RCC) grading before surgery.
METHODS: A total of 73 RCC patients who had undergone preoperative MR imaging and DKI were classified into either a low- grade group or a high-grade group. Parametric DKI maps of each tumor were obtained using in-house software, and histogram metrics between the two groups were analyzed. Receiver operating characteristic (ROC) curve analysis was used for obtaining the optimum diagnostic thresholds, the area under the ROC curve (AUC), sensitivity, specificity and accuracy of the parameters.
RESULTS: Significant differences were observed in 3 metrics of ADC histogram parameters and 8 metrics of DKI histogram parameters (P<0.05). ROC curve analyses showed that Kapp mean had the highest diagnostic efficacy in differentiating RCC grades. The AUC, sensitivity, and specificity of the Kapp mean were 0.889, 87.9% and 80%, respectively.
CONCLUSIONS: DKI histogram parameters can effectively distinguish high- and low- grade RCC. Kapp mean is the best parameter to distinguish RCC grades.

Entities:  

Keywords:  Renal cell carcinoma (RCC); diffusion kurtosis imaging (DKI); histogram analysis; magnetic resonance imaging (MRI)

Year:  2019        PMID: 31143658      PMCID: PMC6511711          DOI: 10.21037/qims.2019.04.14

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  28 in total

1.  Prognostic significance of morphologic parameters in renal cell carcinoma.

Authors:  F Erdoğan; A Demirel; O Polat
Journal:  Int J Clin Pract       Date:  2004-04       Impact factor: 2.503

Review 2.  Renal mass biopsy--a renaissance?

Authors:  Brian R Lane; Mary K Samplaski; Brian R Herts; Ming Zhou; Andrew C Novick; Steven C Campbell
Journal:  J Urol       Date:  2007-11-13       Impact factor: 7.450

3.  Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.

Authors:  K H Tsui; O Shvarts; R B Smith; R A Figlin; J B deKernion; A Belldegrun
Journal:  J Urol       Date:  2000-04       Impact factor: 7.450

4.  Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy.

Authors:  Michael J Leveridge; Antonio Finelli; John R Kachura; Andrew Evans; Hannah Chung; Daniel A Shiff; Kimberly Fernandes; Michael A S Jewett
Journal:  Eur Urol       Date:  2011-06-24       Impact factor: 20.096

5.  Prognostic role of Fuhrman grade and vascular endothelial growth factor in pT1a clear cell carcinoma in partial nephrectomy specimens.

Authors:  D Minardi; G Lucarini; R Mazzucchelli; G Milanese; D Natali; A B Galosi; R Montironi; G Biagini; G Muzzonigro
Journal:  J Urol       Date:  2005-10       Impact factor: 7.450

6.  Diffusional kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging.

Authors:  Jens H Jensen; Joseph A Helpern; Anita Ramani; Hanzhang Lu; Kyle Kaczynski
Journal:  Magn Reson Med       Date:  2005-06       Impact factor: 4.668

7.  Preliminary observations of increased diffusional kurtosis in human brain following recent cerebral infarction.

Authors:  Jens H Jensen; Maria F Falangola; Caixia Hu; Ali Tabesh; Otto Rapalino; Calvin Lo; Joseph A Helpern
Journal:  NMR Biomed       Date:  2010-10-19       Impact factor: 4.044

Review 8.  MRI quantification of non-Gaussian water diffusion by kurtosis analysis.

Authors:  Jens H Jensen; Joseph A Helpern
Journal:  NMR Biomed       Date:  2010-08       Impact factor: 4.044

Review 9.  Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review.

Authors:  Kiran Gupta; Jeffrey D Miller; Jim Z Li; Mason W Russell; Claudie Charbonneau
Journal:  Cancer Treat Rev       Date:  2008-03-04       Impact factor: 12.111

10.  Metastatic ovarian and primary peritoneal cancer: assessing chemotherapy response with diffusion-weighted MR imaging--value of histogram analysis of apparent diffusion coefficients.

Authors:  Stavroula Kyriazi; David J Collins; Christina Messiou; Kjell Pennert; Robert L Davidson; Sharon L Giles; Stan B Kaye; Nandita M Desouza
Journal:  Radiology       Date:  2011-08-09       Impact factor: 11.105

View more
  5 in total

1.  Functional magnetic resonance imaging for distinguishing type of papillary renal cell carcinoma: a preliminary study.

Authors:  Qingqiang Zhu; Jing Ye; Wenrong Zhu; Jingtao Wu; Wenxin Chen; Jun Ling
Journal:  Br J Radiol       Date:  2021-09-07       Impact factor: 3.629

2.  An analysis of Ki-67 expression in stage 1 invasive ductal breast carcinoma using apparent diffusion coefficient histograms.

Authors:  Maolin Xu; Qi Tang; Manxiu Li; Yulin Liu; Fang Li
Journal:  Quant Imaging Med Surg       Date:  2021-04

3.  Application of diffusion kurtosis tensor MR imaging in characterization of renal cell carcinomas with different pathological types and grades.

Authors:  Jie Zhu; Xiaojie Luo; Jiayin Gao; Saying Li; Chunmei Li; Min Chen
Journal:  Cancer Imaging       Date:  2021-03-16       Impact factor: 3.909

4.  Diffusion kurtosis imaging features of renal cell carcinoma: a preliminary study.

Authors:  Qingqiang Zhu; Qing Xu; Weiqiang Dou; Wenrong Zhu; Jingtao Wu; Wenxin Chen; Jing Ye
Journal:  Br J Radiol       Date:  2021-05-14       Impact factor: 3.629

5.  Contrast-enhanced magnetic resonance (MR) T1 mapping with low-dose gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) is promising in identifying clear cell renal cell carcinoma histopathological grade and differentiating fat-poor angiomyolipoma.

Authors:  Shuai Wang; Junheng Li; Diru Zhu; Ting Hua; Binghui Zhao
Journal:  Quant Imaging Med Surg       Date:  2020-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.